Search research articles
Contact Us
Filters
Showing results (301-310 of 388) with videos related to
Page
of 39
Sort By:
Cytometry. Part B, Clinical Cytometry
|
April 27, 2004
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
E Paietta, O Goloubeva, D Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer
J M Bennett, A B Troxel, R Gelman, et al.
American Journal of Hematology
|
April 3, 2001
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity
E Paietta, D Neuberg, S Richards, et al.
Cancer Treatment Reports
|
December 1, 1984
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study
M Levin, K J Pandya, J D Khandekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer
G Falkson, R S Gelman, R Dreicer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1988
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma
J M Bennett, H B Muss, J H Doroshow, et al.
Leukemia & Lymphoma
|
June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)
P H Wiernik, T Leong, M M Oken, et al.
Leukemia
|
August 15, 2000
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)
C Robles, K M Kim, M M Oken, et al.
Critical Reviews in Oncology/Hematology
|
February 16, 2007
Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task force
Silvio Monfardini, M S Aapro, J M Bennett, et al.
Cancer
|
February 1, 1979
Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas
E Z Ezdinli, W Costello, L P Wasser, et al.
Page
of 39
Search research articles
Search
Showing results (301-310 of 388) with videos related to
Sort By:
Page
of 39
Cytometry. Part B, Clinical Cytometry
|
April 27, 2004
A surrogate marker profile for PML/RAR alpha expressing acute promyelocytic leukemia and the association of immunophenotypic markers with morphologic and molecular subtypes
E Paietta, O Goloubeva, D Neuberg, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
April 1, 1994
Myelodysplastic syndrome and acute myeloid leukemia secondary to mitolactol treatment in patients with breast cancer
J M Bennett, A B Troxel, R Gelman, et al.
American Journal of Hematology
|
April 3, 2001
Rare adult acute lymphocytic leukemia with CD56 expression in the ECOG experience shows unexpected phenotypic and genotypic heterogeneity
E Paietta, D Neuberg, S Richards, et al.
Cancer Treatment Reports
|
December 1, 1984
Phase II study of mitoxantrone in advanced breast cancer: an Eastern Cooperative Oncology Group pilot study
M Levin, K J Pandya, J D Khandekar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 1, 1989
Myelodysplastic syndrome and acute nonlymphocytic leukemia secondary to mitolactol treatment in patients with breast cancer
G Falkson, R S Gelman, R Dreicer, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 1, 1988
A randomized multicenter trial comparing mitoxantrone, cyclophosphamide, and fluorouracil with doxorubicin, cyclophosphamide, and fluorouracil in the therapy of metastatic breast carcinoma
J M Bennett, H B Muss, J H Doroshow, et al.
Leukemia & Lymphoma
|
June 28, 2001
Bleomycin, lomustine, cyclophosphamide, vincristine, procarbazine and prednisone (BLEO-CCVPP) in patients with Hodgkin's disease who relapsed after radiotherapy alone: a long-term follow-up study of the Eastern Cooperative Oncology Group (E3481)
P H Wiernik, T Leong, M M Oken, et al.
Leukemia
|
August 15, 2000
Low-dose cytarabine maintenance therapy vs observation after remission induction in advanced acute myeloid leukemia: an Eastern Cooperative Oncology Group Trial (E5483)
C Robles, K M Kim, M M Oken, et al.
Critical Reviews in Oncology/Hematology
|
February 16, 2007
Organization of the clinical activity of geriatric oncology: report of a SIOG (International Society of Geriatric Oncology) task force
Silvio Monfardini, M S Aapro, J M Bennett, et al.
Cancer
|
February 1, 1979
Eastern Cooperative Oncology Group experience with the rappaport classification of non-Hodgkin's lymphomas
E Z Ezdinli, W Costello, L P Wasser, et al.
Page
of 39